Therapeutic Areas
Respiratory
Oncology
Inflammation
Neuroimaging
Liver imaging
Drug Safety Assessment
MRS
Bioxydyn delivers quantitative brain MRS biomarkers with particular expertise in hypoxic-ischaemic encephalopathy (HIE). We design and implement robust in vivo spectroscopy protocols, enabling reliable measurement of cerebral metabolites and treatment response.
MRS
Our experience includes cross-site harmonisation, quality-controlled spectral analysis, and validated quantification pipelines. Through dedicated phantom validation and controlled processing workflows, we ensure spectroscopy biomarkers are reproducible, accurate, and suitable for pharmaceutical-grade studies. We also provide robust de-identifications and data transfer for proprietary MRS formats through VoxelFlow - a real need in this space.
Delivery
Our spectroscopy workflows are designed for consistency across sites and over time. Bioxydyn combines protocol design, training, quality control, and validated analysis pipelines to deliver decision-ready MRS biomarker outputs in early-phase and multicentre studies.
